4,541
Participants
Start Date
April 2, 2024
Primary Completion Date
March 11, 2025
Study Completion Date
March 11, 2025
RSV vaccine candidate
Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection
Placebo
Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection
Investigational Site Number : 0360003, Botany
Investigational Site Number : 0360002, Camberwell
Investigational Site Number : 0360001, Southport
Investigational Site Number : 0360004, Sippy Downs
Investigational Site Number : 0360005, Norwood
Investigational Site Number : 2140001, Santo Domingo
Investigational Site Number : 2140002, Santo Domingo
Investigational Site Number : 3400003, Tegucigalpa
Investigational Site Number : 3400002, Tegucugalpa
Investigational Site Number : 3400001, San Pedro Sula
Investigational Site Number : 4840002, León
Investigational Site Number : 1700007, Santiago de Cali
Investigational Site Number : 4840003, Querétaro
Investigational Site Number : 1700006, Bogotá
Investigational Site Number : 1700003, Girardot
Investigational Site Number : 1700001, Quindío
Investigational Site Number : 1700005, Ibagué
Investigational Site Number : 1700004, Aguazul
Investigational Site Number : 1520006, Concepción
Investigational Site Number : 1520002, Santiago
Investigational Site Number : 1520008, Santiago
Investigational Site Number : 1520005, Santiago
Investigational Site Number : 1520001, Santiago
Investigational Site Number : 1520004, Santiago
Investigational Site Number : 1700002, Barranquilla
Sanofi Pasteur, a Sanofi Company
INDUSTRY